Narrowing the Gap to Diagnose Alzheimer’s Disease Through Biomarkers
Time: 11:45 am
day: Day One
Details:
- Analyzing several biomarkers to understand their use for neuroinflammation in neurodegenerative diseases
- Using CSF biomarkers to narrow the gap to diagnostic tests for Alzheimer’s disease
- Referencing to current human trials of CSF and blood biomarkers to compare the effectivity of blood versus CSF-based biomakers
